← Back to Search

Arista for Blood Loss

Phase 1
Recruiting
Research Sponsored by Virtua Health, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Have the mental capacity to provide consent
Are undergoing a primary unilateral total knee arthroplasty
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours postop, 14 days postop, 3 months post op
Awards & highlights

Study Summary

This trial found that using Arista hemostatic powder resulted in less blood loss, fewer hematomas, and better range of motion after total knee arthroplasty, when compared to patients who did not receive the product.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours postop, 14 days postop, 3 months post op
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours postop, 14 days postop, 3 months post op for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Blood Loss
Secondary outcome measures
Hematoma formation
Range of motion

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Arista groupExperimental Treatment1 Intervention
this group of randomized patients will receive 5 grams of arista hemostatic powder intra-operatively in their wound in addition to 1 gram of IV transexemic acid prior to incision
Group II: control groupActive Control1 Intervention
this group of randomized patients will receive just the 1 gram of IV transexemic acid prior to incision
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Arista
2014
N/A
~70

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

Virtua Health, Inc.Lead Sponsor
8 Previous Clinical Trials
606 Total Patients Enrolled
Becton, Dickinson and CompanyIndustry Sponsor
70 Previous Clinical Trials
88,526 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants are receiving treatment within this clinical trial?

"Confirmed. Per the clinicaltrials.gov website, this medical trial is still in search of participants and was initially posted on May 1st 2021. A total of 60 people are required for completion from one single site."

Answered by AI

To what degree is Arista hazardous to human health?

"Arista has little research-based evidence of efficacy or safety, so it was assigned a rating of 1."

Answered by AI

Are there still openings available for enrolment in this trial?

"Verified. Clinicaltrials.gov indicates that this medical study, which kicked off on May 1st 2021, is actively seeking participants. The trial requires 60 people to be recruited from a single location."

Answered by AI
~16 spots leftby Mar 2025